Toxoplasmic encephalitis after allogeneic hematopoietic stem cell transplantation


Cetinkaya F. I., MUMCU N., KALIN ÜNÜVAR G., Kilic A. U., KAYNAR L.

NORTHERN CLINICS OF ISTANBUL, vol.9, no.3, pp.282-285, 2022 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.14744/nci.2020.66049
  • Journal Name: NORTHERN CLINICS OF ISTANBUL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Central & Eastern European Academic Source (CEEAS), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.282-285
  • Keywords: Allogeneic stem cell transplantation, encephalitis, toxoplasmosis, CEREBRAL TOXOPLASMOSIS, INFECTION, GONDII, RECIPIENT
  • Erciyes University Affiliated: Yes

Abstract

Cerebral toxoplasmosis is a rare but often life-threatening infection after hematopoietic stem cell transplantation (HSCT). In such cases, early diagnosis and initiation of treatment are vital. We describe a case of cerebral toxoplasmosis in a patient who underwent HSCT for acute myeloid leukemia. Infection was diagnosed with polymerase chain reaction (PCR) test of cerebrospinal fluid and cranial magnetic resonance imaging scan. The patient treated with trimethoprim-sulfamethoxazole and clindamycin combination. However, she died from nosocomial infection after 15 days of treatment. This life-threatening infection should be considered in a patient who is post-HSCT present with neurologic symptoms and brain lesions. PCR is an important and rapid diagnostic tool for toxoplasmosis. Cranial imaging scan and PCR should be used together to diagnosed.